Summit Therapeutics PLC (FRA:UVF1)
€ 0.2 0 (0%) Market Cap: 65.72 Mil Enterprise Value: -366.59 Mil PE Ratio: 0 PB Ratio: 29.92 GF Score: 14/100

Summit Therapeutics Inc Extraordinary Shareholders Meeting Transcript

Jul 27, 2022 / NTS GMT
Operator

Good morning, and welcome to Summit Therapeutics, Inc.'s Special Meeting of Stockholders. We do not expect any technical difficulties today. However, in the event that we lose the webcast connection, and we are unable to provide any updates, please wait up to 10 minutes for resolution. Please refer to the company's Investors Relations website for updates.

At this time, I would like to introduce Summit's Chairman and Chief Executive Officer, Bob Duggan.

Bob Duggan
Summit Therapeutics Inc. - CEO

Thank you, and good morning, and afternoon, ladies and gentlemen. Welcome to our Special Stockholders' Meeting. I would like to call this meeting to order.

Attending from our management team with me today, we have Dr. Maky Zanganeh, our co-CEO and President and a member of our Board of Directors; Ankur Dhingra, our Chief Financial Officer; and Dave Gancarz, our Head of Stakeholder Relations and Corporate Strategy. We also have Adam Firemen, a member of our External Counsel team from BakerHostetler.

Today's presentation as well as the rules and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot